Presentation AHA 2017

Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Presenter: Andre Lamy

November 15, 2017

REGISTER for free or LOG IN to view this content

Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Coronary

CAD Pharma

Presentation

AHA 2017

Up Next

Presentation AHA 2017

Insights from the FOURIER Trial

Presenter: Marc P. Bonaca

November 15, 2017

More slides +

Presentation Controversies and Advances 2017

Rise, Fall And Resurrection of Renal Denervation

Presenter: Michael A. Weber

November 16, 2017

Presentation Controversies and Advances 2017

EKG Transmission is NOT Necessary

Presenter: Timothy D. Henry

November 16, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.